UBI Pharma Inc. announced earnings results for the half year ended June 30, 2019. For the half year, the company announced sales was TWD 229.199 million compared to TWD 214.994 million a year ago. Net loss was TWD 107.918 million compared to TWD 107.168 million a year ago. Basic loss per share was TWD 0.76 compared to TWD 0.76 a year ago.